Be part of the knowledge.™

Oncology and Hematology

1026

LikeLikedUnlike

1-15 of 313

Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
CME/CE Virtual Event
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
June 17, 2026
04:30 PM - 05:15 PM CEST
0.75 credits
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
CME/CE Virtual Event
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
June 24, 2026
06:00 PM - 06:45 PM CEST
0.75 credits
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
1.50 credits
NEW EPISODE
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
NEW EPISODE
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
NEW EPISODE
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
- Erica L. Mayer, MD, MPH
0.50 program credits
advertisement
First 5 Minutes®: Empowering Shared Decisions in Lung Cancer Screening
CME/CE
First 5 Minutes®: Empowering Shared Decisions in Lung Cancer Screening
- Brett Bade, MD
- Michael Gieske, MD
0.25 credits
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CE
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
- Jean Hoffman-Censits, MD
0.25 credits
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CE
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
- Kathleen N. Moore, MD, MS
0.25 credits
MinuteCE®
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
- Jennifer Johnson, MD, PhD
- Adam J. Luginbuhl, MD
0.50 credits 5 episodes
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
- Adam J. Luginbuhl, MD
0.50 program credits
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
- Adam J. Luginbuhl, MD
0.50 program credits
advertisement
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
MinuteCE®
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
- Jennifer Johnson, MD, PhD
0.50 program credits
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
- Jennifer Johnson, MD, PhD
0.50 program credits
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
- Adam J. Luginbuhl, MD
- Jennifer Johnson, MD, PhD
0.50 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended